The protective role of Mertk in JEV-induced encephalitis by maintaining the integrity of blood–brain barrier
Virology Journal · 2024
DOI: 10.1186/s12985-024-02472-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virology Journal, 2024. Verfasst von Chuanyu Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Norinco General Hospital, Xi'an, 710065, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, c-Mer Tyrosine Kinase, Encephalitis Virus, Japanese, Encephalitis, Japanese. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Japanese encephalitis is an acute infectious disease of the central nervous system caused by neurotropic Japanese encephalitis virus (JEV). As a member of TAM (Tyro3, Axl and Mertk) family, Mertk has involved in multiple biological processes by engaging with its bridging ligands Gas6 and Protein S, including invasion of pathogens, phagocytosis of apoptotic cells, inflammatory response regulation, and the maintenance of blood brain barrier (BBB) integrity. However, its role in encephalitis caused by JEV infection has not been studied in detail. Here, we found that Mertk-/- mice exhibited higher mortality and more rapid disease progression than wild-type mice after JEV challenge. There were no significant differences in viral load and cytokines expression level in peripheral tissues between Wild type and Mertk-/- mice. Furthermore, the absence of Mertk had little effect on the inflammatory response and immunopathological damage while it can cause an increased viral load in the brain. For the in vitro model of BBB, Mertk was shown to maintain the integrity of the BBB. In vivo, Mertk-/- mice exhibited higher BBB permeability and lower BBB integrity. Taken together, our findings demonstrate that Mertk acts as a protective factor in the development of encephalitis induced by JEV infection, which is mainly associated with its beneficial effect on BBB integrity, rather than its regulation of inflammatory response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Norinco General Hospital, Xi'an, 710065, China.
- Department of Infectious Diseases, Tangdu Hospital, Air Force Medical University, Xi'an, 710032, China.
- Department of Geriatrics, Xijing Hospital, Air Force Medical University, Xi'an, 710032, China.
- Department of Cell Biology, National Translational Science Center for Molecular Medicine, Air Force Medical University, Xi'an, 710032, China.
- Department of Microbiology and Pathogen Biology, School of Basic Medical Sciences, Air Force Medical University, Changle West Road, Xincheng District, Xi'an, 710032, Shaanxi, China.
- Department of Microbiology and Pathogen Biology, School of Basic Medical Sciences, Air Force Medical University, Changle West Road, Xincheng District, Xi'an, 710032, Shaanxi, China. luxin@fmmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Luo, C., Li, M., Bian, P., Yang, J., Liao, X., Dong, Y., Ye, C., Zhang, F., Lv, X., Zhang, Q., & Lei, Y. (2024). The protective role of Mertk in JEV-induced encephalitis by maintaining the integrity of blood–brain barrier. Virology Journal. https://doi.org/10.1186/s12985-024-02472-1
Vancouver
Luo C, Li M, Bian P, Yang J, Liao X, Dong Y, et al. The protective role of Mertk in JEV-induced encephalitis by maintaining the integrity of blood–brain barrier. Virology Journal. 2024. doi:10.1186/s12985-024-02472-1
BibTeX
@article{Luo2024,
author = {Luo, Chuanyu and Li, Mengyuan and Bian, Peiyu and Yang, Jiali and Liao, Xiamei and Dong, Yangchao and Ye, Chuantao and Zhang, Fanglin and Lv, Xin and Zhang, Qianqian and Lei, Yingfeng},
title = {The protective role of Mertk in JEV-induced encephalitis by maintaining the integrity of blood–brain barrier},
journal = {Virology Journal},
year = {2024},
doi = {10.1186/s12985-024-02472-1}
}
EUVIMED